Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 462277012 | Moracizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 462278019 | Moricizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 714656011 | Moracizine hydrochloride 300mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1188380017 | Moracizine hydrochloride 300mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1236120017 | Moracizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1236663015 | Moricizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2154421015 | Moracizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2155444013 | Moricizine hydrochloride 300mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3468980016 | Product containing moracizine hydrochloride 300 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3483367017 | Product containing moracizine hydrochloride 300 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3500185011 | Moracizine hydrochloride 300 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3565209019 | Product containing only moracizine hydrochloride 300 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3565210012 | Product containing only moracizine hydrochloride 300 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3680900017 | Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3680901018 | Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3680902013 | Moracizine 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3680903015 | Moricizine 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 108151001000001114 | Moracizine hydrochloride 300 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Is a | Product containing moracizine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Is a | Product containing moricizine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Class I antiarrhythmic agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Moracizine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Moracizine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Moracizine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Moracizine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Moracizine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Is a | Product containing only moracizine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Moracizine hydrochloride 300mg tablet - product | Is a | False | Product containing precisely moracizine 300 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR